Selective Homing of Human Leukemic B-Cell Precursors to Specific Lymphohematopoietic Microenvironments in SCID Mice: A Role for the β 1 Integrin Family Surface Adhesion Molecules VLA-4 and VLA-5

References

• Springer T. A. Adhesion receptors of the immune system. Nature 1990; 346: 425–434
   PubMed Web of Science ®Google Scholar
• Manabe A., Coustan-Smith E., Behm F. G., Raimondi S. C., Campana D. Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood 1992; 79: 2370–2377
   PubMed Web of Science ®Google Scholar
• Manabe A., Gopal Murti K., Coustan-Smith E., Kumagai M., Behm F. G., Raimondi S. C., Campana D. Adhesion-dependent survival of normal and leukemic human B lymphoblastic leukemia. Blood 1994; 83: 758–766
   PubMed Web of Science ®Google Scholar
• Simmons P. J., Zannettino A., Gronthos S., Leavesley D. Potential adhesion mechanisms for localization of haemopoietic progenitors to bone marrow stroma. Leukemia and Lymphoma 1994; 12: 353–363
   PubMed Web of Science ®Google Scholar
• Dorshkind K. Regulation of hemopoiesis by bone marrow stromal cells and their products. Ann. Rev. Immunol. 1990; 8: 111–137
   PubMed Web of Science ®Google Scholar
• Ryan D. H., Nuccie B. L., Abboud C. N., Winslow J. M. Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells. J. Clin. Invest. 1991; 88: 995–1004
   PubMed Web of Science ®Google Scholar
• Ryan D. H., Nuccie B. L., Abboud C. N. Inhibition of human bone marrow lymphoid progenitor colonies by antibodies to VLA integrins. J. Immunol. 1992; 149: 3759–3764
   PubMed Web of Science ®Google Scholar
• Dittel B. N., McCarthy J. B., Wayner E. A., Lebien T. W. Regulation of human B-cell precursor adhesion to bone marrow stromal cells by cytokines that exert opposing effects on the expression of vascular cell adhesion molecule-1 (VCAM-1). Blood 1993; 81: 2272–2282
   PubMed Web of Science ®Google Scholar
• Tang J., Scott G., Ryan D. H. Subpopulations of bone marrow fibroblasts support VLA-4-mediated migration of B-cell precursors. Blood 1993; 82: 3415–3423
   PubMed Web of Science ®Google Scholar
• Bradstock K., Makrynikola V., Bianchi A., Byth K. Analysis of the mechanism of adhesion of precursor-B acute lymphoblastic leukemia cells to bone marrow fibroblasts. Blood 1993; 82: 3437–3444
   PubMed Web of Science ®Google Scholar
• Makrynikola V., Bradstock K. F. Adhesion of precursor-B acute lymphoblastic leukemia cells to bone marrow stromal proteins. Leukemia 1993; 7: 86–92
   PubMed Web of Science ®Google Scholar
• Bradstock K. F., Gottlieb D. J. Interaction of Acute Leukemia Cells with the Bone Marrow Microenvironment: Implications for Control of Minimal Residual Disease. Leukemia and Lymphoma 1995; 18: 1–16
   PubMed Web of Science ®Google Scholar
• Yoder M. C., Williams D. A. Matrix molecule interactions with hematopoietic stem cells. Exp. Hematol. 1995; 23: 961–967
   PubMed Web of Science ®Google Scholar
• Hynes R. C. Integrins: versatility, modulation, and signalling in cell adhesion. Cell 1992; 69: 11–25
   PubMed Web of Science ®Google Scholar
• Hemler M. E. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu. Rev. Immunol. 1990; 8: 365–400
   PubMed Web of Science ®Google Scholar
• Carlos T. M., Harlan J. M. Leukocyte-Endotheilial adhesion molecules. Blood 1994; 84: 2068–2101
   PubMed Web of Science ®Google Scholar
• Juneja H. S., Rajaraman S., Gay R. E., Gay S., Schmalsteig F. C. Characterization of heterotypic adherence between transformed human lymphoblastic cells and marrow stromal cells. VCAM-1 is a ligand for one of the leukemia adhesion proteins. Exp. Hematol. 1992; 20: 1263–1270
   PubMed Web of Science ®Google Scholar
• Texeido J., Hemler M. E., Greenberger J. S., Anklesaria P. Role of β1 and β2 integrins in the adhesion of human CD34 Hi stem cells to bone marrow stroma. J. Clin. Invest. 1992; 90: 358–367
   PubMed Web of Science ®Google Scholar
• Elices M. J., Osborn L., Takada Y., Crouse C., Luhowskyj S., Hemler M. E., Lobb R. R. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990; 60: 577–584
   PubMed Web of Science ®Google Scholar
• Taichman D. B., Cybulsky M. I., Djaffar I., Longenecker B. M., Teixido J., Rice Ge., Aruffo A., Bevilacqua M. P. Tumour cell surface a4β1 integrin mediates adhesion to vascular endothelium: Demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1. Cell Regu. 1991; 2: 347–355
   PubMedGoogle Scholar
• Kerst J. M., Sanders J. B., Slaper-Cortenbach I. C., Koorakkers M. C., Hooibrind B., Van Oers R. H., Von Dem Borne A. E., Vander Schoot C. E. Alpha 4 beta 1 and alpha 5 beta 1 are differentially expressed during myelopoiesis and mediate the adherence of human CD34+ cells to fibronectin in an activation-dependent way. Blood 1993; 81: 344–351
   PubMed Web of Science ®Google Scholar
• Bernardi P., Patel V. P., Lodish H. F. Lymphoid precursor cells adhere to two different sites on fibronectin. J. Cell Biol. 1987; 105: 489–498
   PubMed Web of Science ®Google Scholar
• Guan J.-L., Hynes Ro. Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor alpha 4 beta 1. Cell 1990; 60: 53–61
   PubMed Web of Science ®Google Scholar
• Mould A., Komoriya A., Yamada K., Humphries M. The CS5 peptide is a second site in the IIICS region of fibronectin recognized by the integrin a4b1. J. Biol. Chem. 1991; 266: 3579
   PubMed Web of Science ®Google Scholar
• Garcia-Pardo A., Ferreira O. Adhesion of human T lymphoid cells to fibronectin is mediated by two different fibronectin domains. Immunology 1990; 69: 121
   PubMed Web of Science ®Google Scholar
• Garcia-Pardo A., Wayner E. A., Carter W. G., Ferreira O. C., Jr. Human B lymphocytes define an alternative mechanism of adhesion to fibronectin. The interaction of the 4β1 integrin with the LHGPEILDVPST sequence of th type 111 connection segment is sufficient to promote cell attachment. J. Immunol. 1990; 144: 3361–3366
   PubMed Web of Science ®Google Scholar
• Ruoslahti E., Pierschbacher M. D. New perspective in cell adhesion: RGD and integrins. Science 1987; 238: 491–497
   PubMed Web of Science ®Google Scholar
• Holzmann B., McIntyre B. W., Weissman, II. Identification of a murine Peyer's patch-specific lymphocyte homing receptor as an integrin molecule with an alpha chain homologous to human VLA-4 alpha. Cell 1989; 56: 37–46
   PubMed Web of Science ®Google Scholar
• Takada Y., Elices M. J., Crouse C., Hemler M. E. The primary structure of the alpha 4 subunit of VLA-4; homology to other integrins and a possible cell-cell adhesion function. EMBO J. 1987; 8: 1361–1368
   Web of Science ®Google Scholar
• Holzmann B., Weissman I. L. Peyer's patch-specific lymphocyte homing receptors consist of a VLA-4-like alpha chain associated with either of two integrin beta chains, one of which is novel. EMBO J. 1989; 8: 1735–1741
   PubMed Web of Science ®Google Scholar
• Miyake K., Weissman I. L., Greenberger J. S., Kincade P. Evidence for a role of the integrin VLA-4 in lymphohemopoiesis. J. Exp. Med. 1991; 173: 599–607
   PubMed Web of Science ®Google Scholar
• Makrynikola V., Bianchi A., Bradstock K., Gottlieb D., Hewson J. Migration of acute lymphoblastic leukemia cells into human bone marrow stroma. Leukemia 1995, in press
   Google Scholar
• Miyake K., Hasunuma Y., Yagita H., Kimoto M. Requirement for VLA-4 and VLA-5 integrins in lymphoma cells binding to and migration beneath stromal cells in culture. J. Cell Biol 1992; 119: 653–662
   PubMed Web of Science ®Google Scholar
• Papayannopoulou T., Nakamoto B. Peripheralization of hematopoietic progenitor cells in primates treated with anti-VLA-4 integrin. Proc. Natl. Acad. Sci. USA 1993; 90: 9374
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Chelstrom L., Finnegan D., Tuel-Ahlgren L., Manivel C., Irvin J., Myers D. E., Gunther R. Effective immunochemotherapy of human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency using B43(anti-CD19) pokeweed antiviral protein immunotoxin plus cyclophosphamide. Blood 1992; 79: 3116
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Downing J. R., Gunther R., Chelstrom L. M., Finnegan D., Land V. J., Borowitz M. J., Carroll Aj., Crist W. M. Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 1993; 81: 3052–3062
   PubMed Web of Science ®Google Scholar
• McCune J. M., Namikawa R., Kaneshima H., Schultz L. D., Lieberman M., Weisman I. L. The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 1988; 241: 1632–1639
   PubMed Web of Science ®Google Scholar
• Mosier D. E., Golizia R. J., Baird S. M., Wilson D. B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335: 256–259
   PubMed Web of Science ®Google Scholar
• Kamel-Reid S., Letarte M., Sirard C., Doedens M., Grunberger T., Fulop G., Freedman M. H., Phillips R. A., Dick J. E. A model of human acute lymphoblastic leukemia in immune-deficient mice. Science 1989; 246: 1597–1600
   PubMed Web of Science ®Google Scholar
• Cesano A., O'Connor R., Lange B., Finan J., Rovera G., Santoli D. Homing and progression patterns of childhood acute lymphoblastic leukemias in severe combined immunodeficiency mice. Blood 1991; 77: 2463–2474
   PubMed Web of Science ®Google Scholar
• Namikawa R., Weilbaecher K. N., Kaneshima H., Yee E. J., McCune J. M. Long-term hematopoiesis in the SCID-hu mouse. J. Exp. Med. 1990; 172: 1055–1063
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Downing J. R., Chelstrom L. M., Gunther R., Ryan M., Simon J., Carroll A. J., Tuel-Ahlgren L., Crist W. M. Human t(4;11)(q21;q23) acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 1994; 84: 859
   PubMed Web of Science ®Google Scholar
• Chelstrom L. M., Gunther R., Simon J., Raimondi S. C., Krance R., Crist W. M., Uckun F. M. Childhood acute myeloid leukemia in mice with severe combined immunodeficiency. Blood 1994; 84: 20
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Sather H., Reaman G., Shuster J., Lan DV., Trigg M., Gunther R., Chelstrom L. M., Gaynon P., Bleyer A., Crist W. Leukemic cell growth in SCID mice as a predictor of relapse in high risk B-lineage acute lymphoblastic leukemia. Blood 1995; 85: 873–878
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Gajl-Peczalska K., Myers D. E., Jaszcz W., Haissig S., Ledbetter J. A. Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells. Blood 1990; 76: 2449–2456
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Ledbetter J. A. Immunobiologic differences between normal and leukemia B-cell precursors. Proc. Natl. Acad. Sci. USA 1988; 85: 8603
   PubMed Web of Science ®Google Scholar
• Downing J. R., Head D. R., Curcio-Brint A. M., Hulshof M. G., Motroni T. A., Raimondi S. C., Corroll A. J., Drabkin H. A., Willman C., Theil K. S., Civin C. I., Erickson P. An AML/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation. Blood 1993; 81: 2860–2865
   PubMed Web of Science ®Google Scholar
• Verfaillie C. M., Benis A., Iida J., McGlave P. B., McCarthy J. B. Adhesion of committed human hematopoietic progeniors to symthetic peptides from the C-terminal heparin-binding domain of fibronectin: cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor. Blood 1994; 84: 1802–1811
   PubMed Web of Science ®Google Scholar
• Szekanecz A., Humphries M. J., Ager A. J. Cell Sci. 1992; 101: 885–894
   PubMed Web of Science ®Google Scholar
• Chan P.-Y., Aruffo A. VLA-4 integrin mediates lymphocyte migration on the inducible endothelial cell ligand VCAM-1 and the extracellular matrix ligand fibronectin. Journal of Biological Chemistry 1993; 268: 24655–24664
   PubMed Web of Science ®Google Scholar